These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 33793424)

  • 1. Accurate diagnosis of pulmonary nodules using a noninvasive DNA methylation test.
    Liang W; Chen Z; Li C; Liu J; Tao J; Liu X; Zhao D; Yin W; Chen H; Cheng C; Yu F; Zhang C; Liu L; Tian H; Cai K; Liu X; Wang Z; Xu N; Dong Q; Chen L; Yang Y; Zhi X; Li H; Tu X; Cai X; Jiang Z; Ji H; Mo L; Wang J; Fan JB; He J
    J Clin Invest; 2021 May; 131(10):. PubMed ID: 33793424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accurate classification of pulmonary nodules by a combined model of clinical, imaging, and cell-free DNA methylation biomarkers: a model development and external validation study.
    He J; Wang B; Tao J; Liu Q; Peng M; Xiong S; Li J; Cheng B; Li C; Jiang S; Qiu X; Yang Y; Ye Z; Zeng F; Zhang J; Liu D; Li W; Chen Z; Zeng Q; Fan JB; Liang W
    Lancet Digit Health; 2023 Oct; 5(10):e647-e656. PubMed ID: 37567793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Gene Expression Classifier from Whole Blood Distinguishes Benign from Malignant Lung Nodules Detected by Low-Dose CT.
    Kossenkov AV; Qureshi R; Dawany NB; Wickramasinghe J; Liu Q; Majumdar RS; Chang C; Widura S; Kumar T; Horng WH; Konnisto E; Criner G; Tsay JJ; Pass H; Yendamuri S; Vachani A; Bauer T; Nam B; Rom WN; Showe MK; Showe LC
    Cancer Res; 2019 Jan; 79(1):263-273. PubMed ID: 30487137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis of Benign and Malignant Pulmonary Ground-Glass Nodules Using Computed Tomography Radiomics Parameters.
    Liang L; Zhang H; Lei H; Zhou H; Wu Y; Shen J
    Technol Cancer Res Treat; 2022; 21():15330338221119748. PubMed ID: 36259167
    [No Abstract]   [Full Text] [Related]  

  • 5. A prediction model based on DNA methylation biomarkers and radiological characteristics for identifying malignant from benign pulmonary nodules.
    Xing W; Sun H; Yan C; Zhao C; Wang D; Li M; Ma J
    BMC Cancer; 2021 Mar; 21(1):263. PubMed ID: 33691657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combining serum miRNAs, CEA, and CYFRA21-1 with imaging and clinical features to distinguish benign and malignant pulmonary nodules: a pilot study : Xianfeng Li et al.: Combining biomarker, imaging, and clinical features to distinguish pulmonary nodules.
    Li X; Zhang Q; Jin X; Cao L
    World J Surg Oncol; 2017 May; 15(1):107. PubMed ID: 28545454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Prediction Models for Identifying Malignancy in Pulmonary Nodules Detected via Low-Dose Computed Tomography.
    González Maldonado S; Delorme S; Hüsing A; Motsch E; Kauczor HU; Heussel CP; Kaaks R
    JAMA Netw Open; 2020 Feb; 3(2):e1921221. PubMed ID: 32058555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A clinically effective model based on cell-free DNA methylation and low-dose CT for risk stratification of pulmonary nodules.
    Liang W; Tao J; Cheng C; Sun H; Ye Z; Wu S; Guo Y; Zhang J; Chen Q; Liu D; Liu L; Tian H; Teng L; Zhong N; Fan JB; He J
    Cell Rep Med; 2024 Oct; 5(10):101750. PubMed ID: 39341207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of malignancy in pulmonary nodules: A validation study of four prediction models.
    Al-Ameri A; Malhotra P; Thygesen H; Plant PK; Vaidyanathan S; Karthik S; Scarsbrook A; Callister ME
    Lung Cancer; 2015 Jul; 89(1):27-30. PubMed ID: 25864782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and validation of an integrated system for lung cancer screening and post-screening pulmonary nodules management: a proof-of-concept study (ASCEND-LUNG).
    Jin Y; Mu W; Shi Y; Qi Q; Wang W; He Y; Sun X; Yang B; Cui P; Li C; Liu F; Liu Y; Wang G; Zhao J; Zhang Y; Zhang S; Cao C; Sun C; Hong N; Cai S; Tian J; Yang F; Chen K
    EClinicalMedicine; 2024 Sep; 75():102769. PubMed ID: 39165498
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Taralli S; Scolozzi V; Foti M; Ricciardi S; Forcione AR; Cardillo G; Calcagni ML
    Eur J Nucl Med Mol Imaging; 2019 Feb; 46(2):429-436. PubMed ID: 30535767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Noninvasive diagnosis of pulmonary nodules using a circulating tsRNA-based nomogram.
    Wang Q; Song X; Zhao F; Chen Q; Xia W; Dong G; Xu L; Mao Q; Jiang F
    Cancer Sci; 2023 Dec; 114(12):4607-4621. PubMed ID: 37770420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-invasive diagnosis of pulmonary nodules by circulating tumor DNA methylation: A prospective multicenter study.
    Li Y; Xie F; Zheng Q; Zhang Y; Li W; Xu M; He Q; Li Y; Sun J
    Lung Cancer; 2024 Sep; 195():107930. PubMed ID: 39146624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Probability of Lung Cancer in Patients With Incidentally Detected Pulmonary Nodules: Clinical Characteristics and Accuracy of Prediction Models.
    Vachani A; Zheng C; Amy Liu IL; Huang BZ; Osuji TA; Gould MK
    Chest; 2022 Feb; 161(2):562-571. PubMed ID: 34364866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimation of malignancy of pulmonary nodules at CT scans: Effect of computer-aided diagnosis on diagnostic performance of radiologists.
    Liu J; Zhao L; Han X; Ji H; Liu L; He W
    Asia Pac J Clin Oncol; 2021 Jun; 17(3):216-221. PubMed ID: 32757455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoantibody Signature Enhances the Positive Predictive Power of Computed Tomography and Nodule-Based Risk Models for Detection of Lung Cancer.
    Massion PP; Healey GF; Peek LJ; Fredericks L; Sewell HF; Murray A; Robertson JF
    J Thorac Oncol; 2017 Mar; 12(3):578-584. PubMed ID: 27615397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of models for predicting the probability of malignancy in patients with pulmonary nodules.
    Li Y; Hu H; Wu Z; Yan G; Wu T; Liu S; Chen W; Lu Z
    Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 32068231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of positron emission tomography/computed tomography and chest thin-layer high-resolution computed tomography for evaluation of pulmonary nodules: Correlation with imaging features, maximum standardized uptake value, and pathology.
    Hou S; Lin X; Wang S; Shen Y; Meng Z; Jia Q; Tan J
    Medicine (Baltimore); 2018 Aug; 97(31):e11640. PubMed ID: 30075545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Establishment and Verification of A Novel Predictive Model of Malignancy
for Non-solid Pulmonary Nodules].
    Xiao F; Yu Q; Zhang Z; Liu D; Liang C
    Zhongguo Fei Ai Za Zhi; 2019 Jan; 22(1):26-33. PubMed ID: 30674390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Multivariate Analysis of Solid Pulmonary Nodules Smaller than 1 cm in 
Distinguishing Lung Cancer from Intrapulmonary Lymph Nodes].
    Tang J; Liu C; Wang P; Cui Y
    Zhongguo Fei Ai Za Zhi; 2021 Feb; 24(2):94-98. PubMed ID: 33508896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.